US FDA Issues Final Guidance On Cybersecurity In Medical Devices

Maryland: The FDA has issued the final guidance Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket SubmissionsThe guidance replaces Content of Premarket Submissions for Management of Cybersecurity in Medical Devices, issued on October 2, 2014.

This document provides recommendations on medical device cybersecurity considerations, device design and labeling, and what information to include in premarket submissions. “These recommendations are intended to promote consistency, facilitate efficient premarket review and help ensure that marketed medical devices are sufficiently resilient to cybersecurity threats,” the FDA states.

The guidance emphasizes that cybersecurity is part of device safety and the quality system requirements found in 21 CFR Part 820, which may be relevant at the premarket stage, postmarket stage or both. It provides recommendations on:

 

  • How connected devices should be tested and validated against breaches that affect multiple connected devices.
  • Provides labeling recommendations for devices with cybersecurity risks.
  • Recommends that companies develop cybersecurity management plans that communicate how they will identify and communicate postmarket vulnerabilities in accordance with 21 CFR 820.100.
  • Recommends that manufacturers provide an updateability and patchability view that describes the end-to-end process that permits software updates and patches to be provided/deployed once the device is in the field.

The guidance recommends that manufacturers use device design processes such as those described in the QS regulation to support secure product development and maintenance. But, to preserve flexibility, they may use other existing frameworks that satisfy the QS regulation and align with FDA’s recommendations for using a Security Product Development Framework (SPDF). Possible frameworks to consider include, but are not limited to, the medical device-specific framework that can be found in the Medical Device and Health IT Joint Security Plan (JSP) 30 and IEC 81001-5-1 or in ANSI/ISA 62443-4-1 Security for industrial automation and control systems Part 4- 1: Product security development life-cycle requirements.

Related Posts

24-year-old woman dies during surgery; Five UP doctors booked for negligence

Ballia: In an alleged case of medical negligence, a case has been registered against five doctors at a private hospital in Ballia, Uttar Pradesh, following the death of a 24-year-old…

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

The yoga guru, who was arrested last week, misled people in the name of faith and Ayurveda, said investigators. Surat: Just days after Ahmedabad cops dismantled a massive fake currency…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

24-year-old woman dies during surgery; Five UP doctors booked for negligence

24-year-old woman dies during surgery; Five UP doctors booked for negligence

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru

Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval

India’s drug body flags 90 unapproved FDC medicines, states told to take action

India’s drug body flags 90 unapproved FDC medicines, states told to take action